Affordable Access

Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.

Authors
Type
Published Article
Journal
European urology
Publication Date
Volume
39
Issue
1
Pages
57–64
Identifiers
PMID: 11173940
Source
Medline
License
Unknown

Abstract

The determination of PSA-ACT or cPSA and the associated ratios do not improve the diagnostic impact to discriminate between PCa and BPH compared to fPSA/tPSA ratio. The ratios PSA-ACT/tPSA or cPSA/tPSA can be considered to be alternative tools of fPSA/tPSA.

Statistics

Seen <100 times